Compare AstraZeneca plc (AZN) vs Kyndryl Holdings Inc (KD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AstraZeneca plc vs Kyndryl Holdings Inc — how do they compare? AstraZeneca plc trades at $158.09 (market cap $248.14B), while Kyndryl Holdings Inc trades at $13.26 (market cap $2.91B). The key difference: AstraZeneca plc is far larger — about 85.3× Kyndryl Holdings Inc's market cap, and AstraZeneca plc pays a 2.01% dividend while Kyndryl Holdings Inc pays none. Which is the better fit depends on your goals.
| AZN | KD | |
|---|---|---|
Market Cap | $248.14B | $2.91B |
Sector | Health | Technology |
52-Week High | $209.48 | $33.14 |
52-Week Low | $147.06 | $10.59 |
Enterprise Value | $275.41B | $5.74B |
Dividend Yield | 2.01% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AstraZeneca plc
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.
Read more on AZN →About Kyndryl Holdings Inc
Kyndryl Holdings Inc is a technology services and infrastructure services provider company. It provides advisory, implementation, and managed services across a range of technology domains to help customers manage and modernize enterprise IT environments in support of their business and transformation objectives.
Read more on KD →
